BACKGROUND: Confocal laser endomicroscopy (CLE) allowing intraoperative near real-time high-resolution cellular visualization is a promising method in neurosurgery. We prospectively tested the accuracy of a new-designed miniatured CLE (CONVIVO® system) in giving an intraoperative first-diagnosis during glioblastoma removal. METHODS: Between January and May 2018, 15 patients with newly diagnosed glioblastoma underwent fluorescein-guided surgery. Two biopsies from both tumor central core and margins were harvested, dividing each sample into two specimens. Biopsies were firstly intraoperatively ex vivo analyzed by CLE, subsequently processed for frozen and permanent fixation, respectively. Then, a blind comparison was conducted between CLE and standard permanent section analyses, checking for CLE ability to provide diagnosis and categorize morphological patterns intraoperatively. RESULTS: Blindly comparing CONVIVO® and frozen sections images we obtained a high rate of concordance in both providing a correct diagnosis and categorizing patterns at tumor central core (80 and 93.3%, respectively) and at tumor margins (80% for both objectives). Comparing CONVIVO® and permanent sections, concordance resulted similar at central core (total/partial concordance in 80 and 86.7% for diagnosis and morphological categorization, respectively) and lower at tumor margins (66.6% for both categories). Time from fluorescein injection and time from biopsy sampling to CONVIVO® scanning was 134 ± 31 min (122-214 min) and 9.23 min (1-17min), respectively. Mean time needed for CONVIVO® images interpretation was 5.74 min (1-7 min). CONCLUSIONS: The high rate of diagnostic/morphological consistency found between CONVIVO® and frozen section analyses suggests the possibility to use CLE as a complementary tool for intraoperative diagnosis of ex vivo tissue specimens during glioblastoma surgery.
BACKGROUND: Confocal laser endomicroscopy (CLE) allowing intraoperative near real-time high-resolution cellular visualization is a promising method in neurosurgery. We prospectively tested the accuracy of a new-designed miniatured CLE (CONVIVO® system) in giving an intraoperative first-diagnosis during glioblastoma removal. METHODS: Between January and May 2018, 15 patients with newly diagnosed glioblastoma underwent fluorescein-guided surgery. Two biopsies from both tumor central core and margins were harvested, dividing each sample into two specimens. Biopsies were firstly intraoperatively ex vivo analyzed by CLE, subsequently processed for frozen and permanent fixation, respectively. Then, a blind comparison was conducted between CLE and standard permanent section analyses, checking for CLE ability to provide diagnosis and categorize morphological patterns intraoperatively. RESULTS: Blindly comparing CONVIVO® and frozen sections images we obtained a high rate of concordance in both providing a correct diagnosis and categorizing patterns at tumor central core (80 and 93.3%, respectively) and at tumor margins (80% for both objectives). Comparing CONVIVO® and permanent sections, concordance resulted similar at central core (total/partial concordance in 80 and 86.7% for diagnosis and morphological categorization, respectively) and lower at tumor margins (66.6% for both categories). Time from fluorescein injection and time from biopsy sampling to CONVIVO® scanning was 134 ± 31 min (122-214 min) and 9.23 min (1-17min), respectively. Mean time needed for CONVIVO® images interpretation was 5.74 min (1-7 min). CONCLUSIONS: The high rate of diagnostic/morphological consistency found between CONVIVO® and frozen section analyses suggests the possibility to use CLE as a complementary tool for intraoperative diagnosis of ex vivo tissue specimens during glioblastoma surgery.
Authors: Nikolay L Martirosyan; Joseph Georges; Jennifer M Eschbacher; Daniel D Cavalcanti; Ali M Elhadi; Mohammed G Abdelwahab; Adrienne C Scheck; Peter Nakaji; Robert F Spetzler; Mark C Preul Journal: Neurosurg Focus Date: 2014-02 Impact factor: 4.047
Authors: Evgenii Belykh; Eric J Miller; Arpan A Patel; Mohammedhassan Izady Yazdanabadi; Nikolay L Martirosyan; Kaan Yağmurlu; Baran Bozkurt; Vadim A Byvaltsev; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: World Neurosurg Date: 2018-04-17 Impact factor: 2.104
Authors: Tejas Sankar; Peter M Delaney; Robert W Ryan; Jennifer Eschbacher; Mohammed Abdelwahab; Peter Nakaji; Stephen W Coons; Adrienne C Scheck; Kris A Smith; Robert F Spetzler; Mark C Preul Journal: Neurosurgery Date: 2010-02 Impact factor: 4.654
Authors: Evgenii Belykh; Nikolay L Martirosyan; Kaan Yagmurlu; Eric J Miller; Jennifer M Eschbacher; Mohammadhassan Izadyyazdanabadi; Liudmila A Bardonova; Vadim A Byvaltsev; Peter Nakaji; Mark C Preul Journal: Front Surg Date: 2016-10-17
Authors: Evgenii Belykh; Eric J Miller; Alessandro Carotenuto; Arpan A Patel; Claudio Cavallo; Nikolay L Martirosyan; Debbie R Healey; Vadim A Byvaltsev; Adrienne C Scheck; Michael T Lawton; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Front Oncol Date: 2019-07-03 Impact factor: 6.244
Authors: Sebastian Foersch; Axel Heimann; Ali Ayyad; Gilles A Spoden; Luise Florin; Konstantin Mpoukouvalas; Ralf Kiesslich; Oliver Kempski; Martin Goetz; Patra Charalampaki Journal: PLoS One Date: 2012-07-24 Impact factor: 3.240
Authors: Aqib H Zehri; Wyatt Ramey; Joseph F Georges; Michael A Mooney; Nikolay L Martirosyan; Mark C Preul; Peter Nakaji Journal: Surg Neurol Int Date: 2014-04-28
Authors: Nicolas Neidert; Jakob Straehle; Daniel Erny; Vlad Sacalean; Amir El Rahal; David Steybe; Rainer Schmelzeisen; Andreas Vlachos; Peter Christoph Reinacher; Volker Arnd Coenen; Boris Mizaikoff; Dieter Henrik Heiland; Marco Prinz; Jürgen Beck; Oliver Schnell Journal: Neurosurg Rev Date: 2021-12-16 Impact factor: 3.042
Authors: Yuan Xu; Irakliy Abramov; Evgenii Belykh; Giancarlo Mignucci-Jiménez; Marian T Park; Jennifer M Eschbacher; Mark C Preul Journal: Front Oncol Date: 2022-08-24 Impact factor: 5.738
Authors: Francesco Restelli; Andrea Maria Mathis; Julius Höhne; Elio Mazzapicchi; Francesco Acerbi; Bianca Pollo; Karl Quint Journal: Front Oncol Date: 2022-10-03 Impact factor: 5.738
Authors: Francesco Restelli; Bianca Pollo; Ignazio Gaspare Vetrano; Samuele Cabras; Morgan Broggi; Marco Schiariti; Jacopo Falco; Camilla de Laurentis; Gabriella Raccuia; Paolo Ferroli; Francesco Acerbi Journal: J Clin Med Date: 2021-05-10 Impact factor: 4.241
Authors: Evgenii Belykh; Naomi R Onaka; Xiaochun Zhao; Irakliy Abramov; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Front Neurol Date: 2021-07-16 Impact factor: 4.003
Authors: Ran Xu; Wanda Teich; Florian Frenzel; Katrin Hoffmann; Josefine Radke; Judith Rösler; Katharina Faust; Anne Blank; Susan Brandenburg; Martin Misch; Peter Vajkoczy; Julia Sophie Onken; Ute Resch-Genger Journal: Front Oncol Date: 2021-05-10 Impact factor: 6.244